Cover Image
市場調查報告書

百日咳菌感染疾病:全球臨床實驗檢討

Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 320346
出版日期 內容資訊 英文 208 Pages
訂單完成後即時交付
價格
Back to Top
百日咳菌感染疾病:全球臨床實驗檢討 Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016
出版日期: 2016年09月30日 內容資訊: 英文 208 Pages
簡介

由微生物百日咳菌引起的傳染病,就稱之為百日咳菌感染疾病。

本報告提供百日咳菌感染疾病的治療藥相關之臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:感染性疾病臨床實驗上百日咳菌感染疾病所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:感染性疾病臨床實驗上百日咳菌感染疾病所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

Phase別臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商類別臨床實驗

有潛力的贊助商

  • 百日咳菌感染疾病的治療藥臨床實驗之主要參與企業

有潛力藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • GlaxoSmithKline plc
    • Sanofi
    • Merck & Co., Inc.
    • Panacea Biotec Limited
    • PT Bio Farma
    • LG Life Sciences, Ltd.
    • Serum Institute of India Limited
    • Novartis AG
    • 第一三共
    • Crucell N.V.
  • 主要大學·研究機關·醫院臨床實驗概要
    • The National Institute of Allergy and Infectious Diseases
    • National Institute for Public Health and the Environment
    • Dalhousie University
    • Statens Serum Institut
    • Health Protection Agency
    • Swedish Institute for Communicable Disease Control
    • Center for Genetic Engineering and Biotechnology
    • Bio-Manguinhos
    • Yale University
    • Memorial Sloan Kettering Cancer Center

主要的臨床簡介

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3790CTIDB

GlobalData's clinical trial report, "Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016" provides an overview of Bordetella pertussis Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Bordetella pertussis Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Five Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Bordetella pertussis Infections to Infectious Disease Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Bordetella pertussis Infections to Infectious Disease Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Bordetella pertussis Infections Therapeutics Clinical Trials 27
  • Prominent Drugs 29
  • Clinical Trial Profile Snapshots 30

Appendix 205

  • Abbreviations 205
  • Definitions 205
  • Research Methodology 206
  • Secondary Research 206
  • About GlobalData 207
  • Contact Us 207
  • Disclaimer 207
  • Source 208

List of Tables

  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Bordetella pertussis Infections Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13
  • Proportion of Bordetella pertussis Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
  • Bordetella pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Bordetella pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Bordetella pertussis Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
  • Bordetella pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Bordetella pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials by Phase, 2016* 20
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Bordetella pertussis Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29

List of Figures

  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Bordetella pertussis Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13
  • Proportion of Bordetella pertussis Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14
  • Bordetella pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15
  • Bordetella pertussis Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16
  • Proportion of Bordetella pertussis Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17
  • Bordetella pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18
  • Bordetella pertussis Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21
  • Bordetella pertussis Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24
  • Bordetella pertussis Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27
  • Bordetella pertussis Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29
  • GlobalData Methodology 206
Back to Top